Intestinal tolerability of nitroxybutyl-flurbiprofen in rats. - Wikidata - wikimedia - TriplyDB

Intestinal tolerability of nitroxybutyl-flurbiprofen in rats.

Intestinal tolerability of nitroxybutyl-flurbiprofen in rats.

http://www.wikidata.org/entity/Q33618082

about

Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs 2, 4-diamino-6- hydroxy pyrimidine inhibits NSAIDs induced nitrosyl-complex EPR signals and ulcer in rat jejunum NO-flurbiprofen reduces amyloid-beta, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade.Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat.Pharmacological agents for the treatment of urinary incontinence due to overactive bladder.Intestinal permeability in the pathogenesis of NSAID-induced enteropathy.Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat.Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism Role of COX-2 in nonsteroidal anti-inflammatory drug enteropathy in rodents.Synthesis and cyclooxygenase inhibitory properties of novel (+) 2-(6-methoxy-2-naphthyl)propanoic acid (naproxene) derivatives.

P2860

Q24672983-D9756DB8-C5E3-4ED8-B314-E76259ED2774 Q24806633-DD65DD0B-947B-4390-B4A7-BBBC5C99969F Q33496256-6096B178-BFDC-4EFE-B432-A4FCBB3F1A72 Q33900286-A600BD35-4320-40E3-A751-D7E22D30222E Q34104589-6B1E2779-3F68-42E7-A34B-EFE0A7B12CA7 Q34923091-867F64D4-9FBA-4A0A-9C46-467303A7A54A Q42061516-3A6398E3-3733-471D-99FA-2A4BA56E4442 Q42128208-36E0B66D-20B6-449A-94FC-5ED1EF71202E Q43074675-CE072485-7026-4061-860A-A0FCE0903487 Q43583914-BE429BF9-6E55-48F1-AFB8-B47507FA892B

P2860

Intestinal tolerability of nitroxybutyl-flurbiprofen in rats.

http://www.wikidata.org/entity/Q33618082

description

1997 nî lūn-bûn

@nan

1997 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Intestinal tolerability of nitroxybutyl-flurbiprofen in rats.

@ast

Intestinal tolerability of nitroxybutyl-flurbiprofen in rats.

@en

type

label

Intestinal tolerability of nitroxybutyl-flurbiprofen in rats.

@ast

Intestinal tolerability of nitroxybutyl-flurbiprofen in rats.

@en

prefLabel

Intestinal tolerability of nitroxybutyl-flurbiprofen in rats.

@ast

Intestinal tolerability of nitroxybutyl-flurbiprofen in rats.

@en

P1433

Q33618082-810BCDE1-B5D0-406B-8379-99D288B872DE

P1476

Q33618082-9D361C37-1B2B-4890-BD39-D376AF81DCC3

P2093

Q33618082-0D4D176B-15A2-4014-A936-0B48A4811A01

Q33618082-21AC811E-92C0-4B7B-B66E-83E8B345888F

Q33618082-2BDF75AB-37EA-42A6-8A2E-5A44C7224C47

Q33618082-8C13E81B-327E-46A2-B52A-CDB0A82747B6

Q33618082-9B79D11D-42D8-4B0E-8516-4503D658F443

Q33618082-A4991036-05BD-4055-9B9D-154EA68DB2CD

Q33618082-B20F88FE-E809-4634-A2ED-5EBDAAB29A86

Q33618082-BDE989F7-3D37-498E-ABEA-CA117F8C3A5A

Q33618082-E1F41787-1F21-47C3-8F15-5AEA67D9D739

Q33618082-E7554F75-0486-479A-B725-23196083BF56

P2860

Q33618082-27648192-8211-4D3E-90C7-EE7A3D27DC52

Q33618082-2F3EE8A7-D2C9-4F10-B908-BE61E78BAD3A

Q33618082-39163668-27C2-4C64-AFFD-B9DF7B79514A

Q33618082-4F8E95C6-7F33-423F-9151-93F9EEC7B57E

Q33618082-517A51DC-1E12-43D4-8F27-747A47A71B02

Q33618082-51EF93B4-7663-4914-B555-F86D315AC7D8

Q33618082-52336FEC-ECF9-48F7-B0D9-E93677B3163E

Q33618082-70725FA5-9622-4C69-AFFC-F5778B5C26F2

Q33618082-9A26734E-4126-4A7E-A50A-CD9DA67F373D

Q33618082-9FDCDFC7-7D1D-4E15-A302-8FC7ED9E1E30

P304

Q33618082-0EB8DEB7-D539-4D35-BC2D-0D658B1D373D

P31

Q33618082-DF7D02B7-DA93-45C7-8E45-B6FE7221F7CE

P356

Q33618082-3D625935-C758-4CA5-8B89-88EEF5145F32

P407

Q33618082-A5402373-9F34-40CF-B54F-D4411F5D75F7

P433

Q33618082-F9B7AE33-277D-44F3-B450-7336333ECD0D

P478

Q33618082-F42CC6BF-95B3-4405-99E6-3649303E5AB4

P577

Q33618082-B10D0FE8-4A13-4383-A241-353DD94E7AED

P5875

Q33618082-799675B9-DF10-4294-905B-392AF386C685

P698

Q33618082-2954FBF4-031E-433D-9141-FD70004DCAB5

P921

Q33618082-EC9CB293-E0BE-4B77-98A6-A6A3ECBEE639

P932

Q33618082-3FBA64E0-6A69-4739-8135-4CA778BC5546

P356

P1433

P1476

Intestinal tolerability of nitroxybutyl-flurbiprofen in rats.

@en

P2093

Bjarnason I

http://www.w3.org/2001/XMLSchema#string

Jacob M

http://www.w3.org/2001/XMLSchema#string

Macpherson A

http://www.w3.org/2001/XMLSchema#string

Mahmud T

http://www.w3.org/2001/XMLSchema#string

Price AB

http://www.w3.org/2001/XMLSchema#string

Rafi S

http://www.w3.org/2001/XMLSchema#string

Scott D

http://www.w3.org/2001/XMLSchema#string

Sherwood R

http://www.w3.org/2001/XMLSchema#string

Sigthorsson G

http://www.w3.org/2001/XMLSchema#string

Somasundaram S

http://www.w3.org/2001/XMLSchema#string

P2860

The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat

Studies on the in vivo absorption of micellar solutions of tocopherol and tocopheryl acetate in the rat: demonstration and partial characterization of a mucosal esterase localized to the endoplasmic reticulum of the enterocyte.

Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man

Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration

Tissue destruction by neutrophils.

The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis.

The 1994 Merck Frosst Award. Mechanisms of nonsteroidal anti-inflammatory drug (NSAID) induced gastrointestinal damage--potential for development of gastrointestinal tract safe NSAIDs.

Activation factors of neutrophil NADPH oxidase complex.

Anti-inflammatory/anti-pyretic salicylic acid esters with low gastric ulcerogenic activity.

P304

608-613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.40.5.608

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

1997-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14015299

http://www.w3.org/2001/XMLSchema#string

P698

9203938

http://www.w3.org/2001/XMLSchema#string

P921

nitroflurbiprofen

P932

1027162

http://www.w3.org/2001/XMLSchema#string